Cloniprazepam

From WikiMD's WELLNESSPEDIA

File:Cloniprazepam.png
Cloniprazepam

Cloniprazepam is a benzodiazepine derivative and a psychoactive drug that has sedative, hypnotic, anxiolytic, and muscle relaxant properties. It is a chlorinated derivative of nitrazepam, a well-known benzodiazepine drug used for the treatment of insomnia and anxiety disorders. Cloniprazepam itself is not approved for medical use in many countries and is often encountered on the designer drug market where it is used for recreational purposes and self-medication.

Chemistry[edit]

Cloniprazepam, chemically known as 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one, is part of the benzodiazepine class of compounds. It has a core benzodiazepine structure with a nitro group (NO2) at the 7 position and a chlorine atom at the 2' position on the phenyl ring. This structural modification contributes to its pharmacological properties, distinguishing it from its parent compound, nitrazepam.

Pharmacology[edit]

As with other benzodiazepines, cloniprazepam acts on the GABAA receptor in the brain. It enhances the effect of the neurotransmitter GABA (gamma-aminobutyric acid), which is the primary inhibitory neurotransmitter in the brain. The activation of GABAA receptors opens chloride channels leading to an influx of chloride ions into the neuron, making it more resistant to depolarization. This mechanism underlies the sedative, anxiolytic, muscle relaxant, and anticonvulsant effects of benzodiazepines.

Effects[edit]

The effects of cloniprazepam can include sedation, relaxation, reduction of anxiety, and suppression of seizures. However, its use is also associated with risks such as dependence, tolerance, and withdrawal symptoms upon cessation. The recreational use of cloniprazepam and other designer benzodiazepines can lead to adverse effects, including severe sedation, respiratory depression, amnesia, and impaired motor functions.

Legal Status[edit]

The legal status of cloniprazepam varies by country, but it is often listed as a controlled substance due to its potential for abuse, dependence, and harm. In jurisdictions where it is controlled, possession, distribution, and manufacture of cloniprazepam without a license are prohibited.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.